Role of sialylation in determining the pharmacokinetics of neutrophil inhibitory factor (NIF) in the Fischer 344 rat

References

• ASHWELL, G. and KAWASAKI, T., 1978, A protein from mammalian liver that specifically binds galactose terminated glycoproteins. Methods in Enzymology, 50, 287–288.
   PubMedGoogle Scholar
• Bocci, V., 1976, The role of sialic acid in determining the life span of circulating cells and proteins. Experientia, 32, 135–140.
   PubMedGoogle Scholar
• Bocci, V., SATOH, Y., PACINI, A., PESSINA, G. P., PAULESU, L. and MUSCETTOLA, M., 1987, Metabolic behaviour of recombinant interferons fi. Medicinal Science Research, 15, 187–188.
   Google Scholar
• DAI, J., DT, W., ATKINSON, J. W., Cox, J. G. and DEMBINSKI, T. C., 1996, Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid cancer. Clinical Biochemistry, 29, 461–465.
   PubMedGoogle Scholar
• DAvrEs, B. and MORRIS, T., 1993, Physiological parameters in laboratory animals and humans. Pharmaceutical Research, 7, 1093–1095.
   Google Scholar
• FESTINTG, M. F., 1993, Genetic variation in outbred rats and mice and its implications for toxicology screening. Journal of Experimental Animal Science, 35, 210–220.
   PubMedGoogle Scholar
• GARDNER, I. B., WALKER, D. K., LENNARD, M. S., SMITH, D. A. and TUCKER, G. T., 1995, Comparison of the disposition of two novel combined thromboxane synthase inhibitors/thromboxane A2 receptor antagonists in the isolated perfused rat liver. Xenobiotka, 25, 185–187.
   PubMed Web of Science ®Google Scholar
• JIANG, N., CHOPP, M. and CHAHWALA S., 1998, Neutrophil inhibitory factor treatment of focal cerebral ischemia in the rat. Brain Research, 788, 25–34.
   Google Scholar
• JIANG, N., MOYLE, M., SOULE, H. R., Rom, W. E. and CHOPP, M., 1995, Neutrophil inhibitory factor is neuroprotective after focal ischemia in rats. Annals of Neurology, 38, 935–942.
   PubMed Web of Science ®Google Scholar
• KNIPPIN G., GOGG-FOSSOLIER, G., FROHNWIESSER, B., KREMPLER, F., KOSINER, G. M. and MALLE E., 1997, Quantification of apolipoprotein D by an immunoassay with time-resolved fluoresence spectroscopy. Journal of Immunological Methods, 202, 85–95.
   Google Scholar
• LEE, Y. C., TOWNSEND, R. R., HARDY, M. R., LONNGREN, J., ARNARP, J., HARALDSSON, M. and LONN, H., 1993, Binding of synthetic oligosaccharides to the hepatic Gal/GalNAc Lectin. Journal of Biological Chemistry, 258, 199–202.
   Google Scholar
• LEFORT, G. P., STOLK, J. M. and NISULA, B. C., 1984, Evidence that desialylation and uptake by hepatic receptors for galactose terminated glycoproteins are immaterial to the metabolism of human choriogonadotrophin in the rat. Endocrinology, 115, 1151–1557.
   PubMedGoogle Scholar
• MORDENTI, J., CHEN, S. A., MOORE, J. A., FERRAIOLO, B. L. and GREEN, J. D., 1991, Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharmaceutical Research, 8, 1351–1359.
   PubMed Web of Science ®Google Scholar
• MORELL, A. G., GREGORIADIS, G., SCHEINBERG, I. H., HICKMAN, J. and ASHWELL, G., 1971, The role of sialic acid in determining the survival of glycoproteins in the circulation. Journal of Biological Chemistry, 246, 1461–1467.
   PubMed Web of Science ®Google Scholar
• MORELL, A. G., IRvrNE, R. A., STERNLIEB, I., SCHEINBERG, I. H. and ASHWELL, G., 1968, Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid free ceruloplasmin in vivo. Journal of Biological Chemistry, 243, 155–159.
   PubMed Web of Science ®Google Scholar
• MOYLE, M., FOSTER, D. L., MCGRATH, D. E., BROWN, S. M., LAROCHE, Y., DE MEUTTER, J., STANSSENS P., BOGOWITZ CA., FRIED, V. A., ELY, J. A., SOULE, HR. and VLASUK, G. P., 1994, A hookworm glycoprotein that inhibits neutrophil function is a ligand of the integrin CD11b/CD18*. Journal of Biological Chemistry, 269, 10008–10015.
   Google Scholar
• RICHTER, W. F., GALLATI, H. and SCHILLER, C. D., 1999, Animal pharmacokinetics of the tumar necrosis factor receptor-immunoglobulin fusion protein Lenercept and their extrapolation to humans. Journal of the American Society of Pharmacology and Experimental Therapeutics, 27, 21–25.
   Google Scholar
• RONNBLOM, L. E., PERERS, A., VALLIN, H. S., ERIKSSON, I., OSIERLIND, A., CEDERBLAD, B. and ALm, G., 1997, Detection of serum interferon-a by dissociation-enhanced lanthanide fluoroimmunoassay; studies of patients with acute viral and bacterial infections. APMIS, 105, 531–536.
   PubMed Web of Science ®Google Scholar
• STRANG, E., Roos, N., SCHLUETER, M., BERG, T. and KRAUSE, J., 1992, Evidence for a carbohydrate-independent endocytosis of tissue-type plasminogen activator. Biochemical Journal, 285, 799–804.
   PubMedGoogle Scholar
• TAVASSOLI, M., 1985, Liver endothelium binds, transports and desialylates ceruloplasmin which is then recognised by galactosyl receptors of the hepatocytes. Transactions of the Association of American Physicians, 98, 370–377.
   PubMedGoogle Scholar
• TAVASSOLI M., KISHEVIOTO, T. and KATAOKA, M., 1986, Liver endothelium mediates the hepatocytes uptake of ceruloplasmin. Journal of Cell Biology, 102, 1298–1303.
   PubMedGoogle Scholar
• VAN DEN HAMER, C. J. A., MORELL, A. G., SCHEINBERG, I. H., HICKMAN, J. and ASHWELL, G., 1970a, Physical and chemical studies on ceruloplasmin. VIII. Preparation of N-acetylneuraminic acid-C-labeled ceruloplasmin. Journal of Biological Chemistry, 245, 759–766.
   Google Scholar
• VAN DEN HAMER, C. J. A., MORELL, A. G., SCHEINBERG, I. H., HICKMAN, J. and ASHWELL, G., 1970b, Physical and chemical studies on ceruloplasmin. IX The role of galactosyl residues in the clearance of ceruloplasmin from the circulation. Journal of Biological Chemistry, 245, 4397–402.
   Google Scholar
• VAN DER SLUIJS, P., OOSTING, R., WEITLRING, J. G., HARDONK, M. J. and MEIJER, D. K. F., 1985, Biliary excretion of FITC metabolites after administration of FITC labelled asiolo orosomuciod as a measure of lysosomal proteolysis. Biochemical Pharmacology, 34, 1399–1405.
   PubMedGoogle Scholar
• VENERANDO, B., FOIRILLA, A., CROCI, G. L. and TETTAMANIT, G., 1997, Presence in human erythrocyte membrane of a novel form of sialidase acting at neutral pH. Blood, 90, 2047–2056.
   PubMed Web of Science ®Google Scholar
• WARREN, L., 1959, The thiobarbituric acid assay of sialic acids. Journal of Biological Chemistry, 234, 1971–1975.
   PubMed Web of Science ®Google Scholar
• WICHER, I., SATTLER W., IBOVNIK, A., KOSTNER, G. M., ZECHNER, R. and MALLE, E., 1996, Quantification of lipoprotein lipase (LPL) by dissociation-enhanced lanthanide fluorescence immunoassay. Comparison of immunoreactivity of LPL mass and enzyme activity of LPL. Journal of Immunological Methods, 192, 1–11.
   Google Scholar
• WOLFE, S. L., 1993, Protein sorting, distribution, secretion and endocytosis. In S. L. Wolfe (ed.), Molecular and Cellular Biology (Belmonte: Wadworth), pp. 825–873.
   Google Scholar